WO2008114186A2 - Device for the production of low-frequency ultrasound for cellulite and localised adiposity treatment - Google Patents
Device for the production of low-frequency ultrasound for cellulite and localised adiposity treatment Download PDFInfo
- Publication number
- WO2008114186A2 WO2008114186A2 PCT/IB2008/050961 IB2008050961W WO2008114186A2 WO 2008114186 A2 WO2008114186 A2 WO 2008114186A2 IB 2008050961 W IB2008050961 W IB 2008050961W WO 2008114186 A2 WO2008114186 A2 WO 2008114186A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound
- transducer
- cellulite
- plate
- handle
- Prior art date
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 28
- 208000035484 Cellulite Diseases 0.000 title claims abstract description 9
- 206010049752 Peau d'orange Diseases 0.000 title claims abstract description 9
- 230000036232 cellulite Effects 0.000 title claims abstract description 9
- 208000023184 Body fat disease Diseases 0.000 title claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 title description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 230000026683 transduction Effects 0.000 claims description 3
- 238000010361 transduction Methods 0.000 claims description 3
- 239000004020 conductor Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 210000001789 adipocyte Anatomy 0.000 abstract description 10
- 230000009471 action Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000009103 reabsorption Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0245—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0008—Destruction of fat cells
Definitions
- the present invention refers to a device to be used for the therapeutic treatment of localised adiposity by ultrasound hydrolipoclasia.
- Subcutaneous fat tissue is a tissue comprised of fibers and fat, lying between the derm (cutaneous layer located under the epidermis) and the muscle fascia. It constitutes the deepest layer of the skin, and establishes a weak bond between skin and inner organs covered thereby. It substantially performs the functions of protecting deeper tissues from any trauma, representing reserves of strength and limiting loss of heat, contributing to keep body temperature constant.
- Adipose tissue is substantially formed by adipocyte cells. These are cells having the ability to synthesize and store triglycerides therein. Moreover, adipocyte cells (or simply “adipocytes”) tend to gather together into lobules, generally forming the so-called “panniculus adiposus”.
- cellulite suggests a tissue pathology of inflammatory origin (in Italian medical language, the suffix ite indicates an inflammation).
- cellulite substantially consists in an inflammation that affects the panniculus adiposus, causing an alteration of the latter. As a consequence of this alteration, it is determined an increase in the adipocyte volume, with the entailed transudation of liquids inside the intercellular spaces.
- Cellulite mainly occurring in women, is an actual condition of tissues that does not merely manifest itself in an unaesthetic way, but can also cause cumbersome pains and anyhow constitute a general discomfort of the body. It, as it is known, causes skin surface to assume the characteristic "orange peel” or “mattress” appearance, exhibiting a series of more or less extended swellings. Zones most affected are the hips, buttocks and thighs. Description of the prior art
- Numerous devices based on the principle of generation of pressure waves with a cavitational effect are currently available on the market. They substantially consist of an apparatus comprising a handle that is placed into contact with the body part to be treated. Said handle comprises a transducer of piezoelectric material that performs the transduction of an electric signal received thereby and emits ultrasound into the biological tissues treated. Said devices however, as witnessed by results directly observed on patients, yield mixed and often disappointing results. In fact, at best, patients attain only a draining of the liquids stagnating into tissues, liquids that therefore subsequently tend to be easily reintegrated. This is mostly due both to the frequency values of the ultrasound waves used, generally very high and of the order of MHz, and to the typology of handle used. Therefore, to date most of the times it is carried out only the absorption of liquids formed inside the panniculus adiposus.
- Object of the present invention is to solve the above-mentioned drawbacks by providing a system as substantially described in claim 1.
- the present invention by overcoming the mentioned problems of the known art, entails several evident advantages.
- the device subject-matter of the present invention proposes the innovative use of ultrasound waves inside of a precise range of frequencies with values ranging from 35 KHz to 55 KHz, sufficiently low to create a localised action on adipocyte cells and allow a dissolving of the fat, yet such as to cause no damage to the surrounding tissues.
- the precise range of low-frequency ultrasound employed by the device subject-matter of the present invention allows the production of a quantity of energy predetermined and targeted solely to adipose tissue.
- ultrasound waves converge and concentrate on focalised zones, producing the immediate effect of rupture of adipocytes and emission of triglycerides, which are then quickly and naturally metabolised.
- the range of frequencies used by the device results in the latter acting on adipose tissue only, thereby entailing a safe and effective fat-reducing and volume-decreasing action.
- the results observed were immediate and measurable, even after only one treatment session (with a reduction of the treated area periphery of up to 2 cm).
- figure 1 shows a block diagram of the device according to the present invention
- figure 2 shows an elevation view of a preferred embodiment of the device subject-matter of the present invention
- figure 2A depicts a detail not shown in figure 2
- figure 3 shows a detail of the embodiment of the device subject-matter of the present invention
- figure 4 shows a situation of use of the device subject-matter of the present invention.
- FIG. 1 it schematizes the operation of a device 1 according to the present invention.
- a voltage generator 2 that sends an electric signal to a transducer 5, which performs a transduction of said electric signal into an acoustic pressure signal at frequencies higher than the human audibility range (ultrasound).
- the adjustment of said voltage generator 2 occurs by means of a programmable control and adjustment microprocessor unit 6 (microcontroller adjustment unit 6), in turn managed by the operator by interface means 7.
- Said voltage generator and control unit are components well-known in the current state of the art, therefore hereinafter a detailed description thereof will be omitted.
- FIG 2 a preferred embodiment of the device 1 subject-matter of the present invention is depicted by way of example and not for limitative purposes.
- Said device 1 comprises a body 20, having at its base a carriage 21 in order to be easily transportable.
- said control unit 6 and said voltage generator 2 (not shown in figure).
- the electric signal produced by the voltage generator is sent, via connecting means 26, to a pair of twin handles 3.
- said handles 3 are preferably arranged, when not in operation, on a pair of shelves 22, integral to said body 20.
- said connecting means 26 is of wire type. The availability of a pair of handles can prove particularly convenient, as it provides the option of concomitantly treating two patients, or of concomitantly treating two different zones of the same patient.
- human - machine interface means 7 comprising, by way of example and not for limitative purposes, a display and a keyboard.
- an operator has the option of adjusting and programming the operation of the device 1 , e.g., by setting treatment times, power used, frequencies and emission times of the ultrasound produced.
- Said interface means could also be made by more advanced technologies, e.g. by equipping said device 1 with a "touch - screen" type terminal.
- said handle 3 has a first grip member 30 connected with a plate 4, made of conducting material and preferably of steel, having cylindrical shape.
- Said steel plate 4 has an elevated thickness of height equal to about 1.5 cm.
- the transducer 5 Directly on a free circular surface 31 of said steel plate 4 it is attached, in a concentric position, the transducer 5.
- Said transducer 5, made of piezoelectric material, has it also a cylindrical shape and has a diameter smaller than the diameter of said circular surface 31.
- the electric signal coming from said generator 2, sent on said steel plate 4 by said connecting means 26, establishes therein an electric field entailing a deformation of the piezoelectric transducer 5 attached thereon.
- the properties of piezoelectric materials are well known in the literature; therefore the principles underlying their use in the art will be omitted, their practical implementation being within the reach of a person skilled in the art.
- the device subject-matter of the present invention uses ultrasound with frequency values ranging from 35 kHz to 55 kHz.
- frequency values ranging from 35 kHz to 55 kHz.
- a frequency value close to 40 KHz is set.
- a frequency value close to 50 KHz is set.
- said grip member 30 comprises, at an edge thereof, a ring-shaped luminous indicator 9, active under conditions of use of the device. This provides an immediate reference for the operator, indicating the operativeness of the device itself.
- FIG 4 it is depicted a situation of use of the device 1 subject-matter of the present invention.
- the handle 3 brought into contact with a patient's skin at the piezoelectric transducer 5, attached onto the surface 31 of the steel plate 4.
- Body parts most often subject of the therapy are abdomen, girdle, hips (a body part also known as “saddle bags"), inner thighs and the back of the knees.
- the present invention has hereto been described with reference to a preferred embodiment thereof. It is understood that other embodiments might exist, all falling within the concept of the same invention, and all comprised within the protective scope of the claims hereinafter.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Surgical Instruments (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Device for cellulite and localised adiposities cure by ultrasound hydrolipoclasia, producing ultrasound with a frequency ranging between the values of 35 KHz and 55Khz, using an innovative-type handle in order to create, besides a draining effect, an action targeted at the elimination and subsequent reabsorption of adipocyte cells.
Description
Device for the production of low-frequency ultrasound for cellulite and localised adiposity treatment
DESCRIPTION
The present invention refers to a device to be used for the therapeutic treatment of localised adiposity by ultrasound hydrolipoclasia. Technology history Subcutaneous fat tissue is a tissue comprised of fibers and fat, lying between the derm (cutaneous layer located under the epidermis) and the muscle fascia. It constitutes the deepest layer of the skin, and establishes a weak bond between skin and inner organs covered thereby. It substantially performs the functions of protecting deeper tissues from any trauma, representing reserves of strength and limiting loss of heat, contributing to keep body temperature constant.
Adipose tissue is substantially formed by adipocyte cells. These are cells having the ability to synthesize and store triglycerides therein. Moreover, adipocyte cells (or simply "adipocytes") tend to gather together into lobules, generally forming the so-called "panniculus adiposus".
Etymologically, the term "cellulite" suggests a tissue pathology of inflammatory origin (in Italian medical language, the suffix ite indicates an inflammation).
This word, though not exact, has however entered in common (Italian) language, and is widely accepted to indicate a specific type of problem involving the panniculus adiposus.
Considering that to date cellulite genesis still is a phenomenon not altogether clear, and therefore object of numerous studies, cellulite substantially consists in an inflammation that affects the panniculus adiposus, causing an alteration of the latter. As a consequence of this alteration, it is determined an increase in the adipocyte volume, with the entailed transudation of liquids inside the intercellular spaces.
Cellulite, mainly occurring in women, is an actual condition of tissues that does not merely manifest itself in an unaesthetic way, but can also cause cumbersome pains and anyhow constitute a general discomfort of the body. It, as it is known, causes skin surface to assume the characteristic "orange peel" or "mattress" appearance, exhibiting a series of more or less extended swellings. Zones most affected are the hips, buttocks and thighs.
Description of the prior art
From common literature, several (non-invasive) methodologies are known for the cure of cellulite or, more generally, the decrease of adipose tissue. Among those, in the last few years cavitational-effect ultrasound hydrolipoclasia has taken hold. It is a non-invasive method for the pathology treatment that aims to reduce adipocytes in volume by use of ultrasound acoustic pressure waves, or "ultrasound". The prefix "ultra" implies that said ultrasound is emitted with frequencies outside of the audibility range for the human ear. Said ultrasound is produced by electro-acoustic transducers: in particular, in this type of applications, ultrasound is artificially produced by means of the characteristics of a piezoelectric material. By applying an AC field on the faces of such a piezoelectric material, there can be obtained thereon an alternation of compressions and decompressions at very high frequencies, producing a field of ultrasound sound waves. By travelling through tissues these ultrasound waves cede thereto, by the known "attenuation" phenomenon, part of their energy.
As it is known in the current state of the art, inside tissues these waves determine a physical phenomenon of "ultrasound cavitation". It is a phenomenon occurring in a liquid subjected to an acoustic wave field, when dynamic negative pressures cause local pressure to drop below the saturation pressure of gases dissolved therein, or below the vapour pressure of the liquid itself. This situation entails, inside the liquid, development of vapour in the form of fine bubbles that become larger during the length of the decompression phase, whereas in the subsequent compression phase they implode, releasing impact energy into the tissues. This released energy causes damages to the surrounding structures, contributing to adipocyte cell fragmentation. Drawbacks of the prior art
Numerous devices based on the principle of generation of pressure waves with a cavitational effect are currently available on the market. They substantially consist of an apparatus comprising a handle that is placed into contact with the body part to be treated. Said handle comprises a transducer of piezoelectric material that performs the transduction of an electric signal received thereby and emits ultrasound into the biological tissues treated. Said devices however, as witnessed by results directly observed on patients, yield mixed and often disappointing results. In fact, at best, patients attain
only a draining of the liquids stagnating into tissues, liquids that therefore subsequently tend to be easily reintegrated. This is mostly due both to the frequency values of the ultrasound waves used, generally very high and of the order of MHz, and to the typology of handle used. Therefore, to date most of the times it is carried out only the absorption of liquids formed inside the panniculus adiposus.
Hence, the solutions provided by the modern art entail provisional improvements, yet fail in the attempt at offering a final solution to the problem. Objects of the invention
Object of the present invention is to solve the above-mentioned drawbacks by providing a system as substantially described in claim 1.
Further features of the system are defined in the corresponding dependent claims thereof. Advantages of the invention
The present invention, by overcoming the mentioned problems of the known art, entails several evident advantages.
In fact, the device subject-matter of the present invention proposes the innovative use of ultrasound waves inside of a precise range of frequencies with values ranging from 35 KHz to 55 KHz, sufficiently low to create a localised action on adipocyte cells and allow a dissolving of the fat, yet such as to cause no damage to the surrounding tissues.
Therefore, the precise range of low-frequency ultrasound employed by the device subject-matter of the present invention allows the production of a quantity of energy predetermined and targeted solely to adipose tissue. In fact, differently from similar devices available on the market, ultrasound waves converge and concentrate on focalised zones, producing the immediate effect of rupture of adipocytes and emission of triglycerides, which are then quickly and naturally metabolised. Hence, the range of frequencies used by the device results in the latter acting on adipose tissue only, thereby entailing a safe and effective fat-reducing and volume-decreasing action. The results observed were immediate and measurable, even after only one treatment session (with a reduction of the treated area periphery of up to 2 cm). Moreover, the specific and innovative typology of handle employed by the device, having a greater thickness than those commonly employed in the art,
besides giving specific effectiveness to the ultrasound waves emitted entails for treated patients a specific comfort, perceived during and after the treatment session, as well as satisfaction and wish to continue the treatment.
At the end of a session, taking place in the total absence of anaesthesia, immediate resumption of activities was observed in patients; this being further corroborated by the total absence of side effects.
Brief description of the drawings
Still further advantages, as well as the features and the operation steps of the present invention will be made apparent in the following detailed description of a preferred embodiment thereof, given by way of example and not for limitative purposes. Reference will be made to the figures of the annexed drawings, wherein: figure 1 shows a block diagram of the device according to the present invention; figure 2 shows an elevation view of a preferred embodiment of the device subject-matter of the present invention; figure 2A depicts a detail not shown in figure 2; figure 3 shows a detail of the embodiment of the device subject-matter of the present invention; and figure 4 shows a situation of use of the device subject-matter of the present invention.
Detailed description of the drawings
In particular, referring to figure 1 , it schematizes the operation of a device 1 according to the present invention. Therein, it is present a voltage generator 2 that sends an electric signal to a transducer 5, which performs a transduction of said electric signal into an acoustic pressure signal at frequencies higher than the human audibility range (ultrasound). The adjustment of said voltage generator 2 occurs by means of a programmable control and adjustment microprocessor unit 6 (microcontroller adjustment unit 6), in turn managed by the operator by interface means 7. Said voltage generator and control unit are components well-known in the current state of the art, therefore hereinafter a detailed description thereof will be omitted.
Referring to figure 2, a preferred embodiment of the device 1 subject-matter of the present invention is depicted by way of example and not for limitative purposes.
Said device 1 comprises a body 20, having at its base a carriage 21 in order
to be easily transportable.
Inside said body 20 are present said control unit 6 and said voltage generator 2 (not shown in figure). The electric signal produced by the voltage generator is sent, via connecting means 26, to a pair of twin handles 3. As better highlighted in figure 2A, said handles 3 are preferably arranged, when not in operation, on a pair of shelves 22, integral to said body 20. In the preferred embodiment, shown here by way of example and not for limitative purposes, said connecting means 26 is of wire type. The availability of a pair of handles can prove particularly convenient, as it provides the option of concomitantly treating two patients, or of concomitantly treating two different zones of the same patient.
Moreover, on said body 20 it is obtained human - machine interface means 7, comprising, by way of example and not for limitative purposes, a display and a keyboard. By said interface, connected to said control unit 6, an operator has the option of adjusting and programming the operation of the device 1 , e.g., by setting treatment times, power used, frequencies and emission times of the ultrasound produced. Said interface means could also be made by more advanced technologies, e.g. by equipping said device 1 with a "touch - screen" type terminal. In particular, referring to figure 3, said handle 3 has a first grip member 30 connected with a plate 4, made of conducting material and preferably of steel, having cylindrical shape. Said steel plate 4 has an elevated thickness of height equal to about 1.5 cm. Directly on a free circular surface 31 of said steel plate 4 it is attached, in a concentric position, the transducer 5. Said transducer 5, made of piezoelectric material, has it also a cylindrical shape and has a diameter smaller than the diameter of said circular surface 31. The electric signal coming from said generator 2, sent on said steel plate 4 by said connecting means 26, establishes therein an electric field entailing a deformation of the piezoelectric transducer 5 attached thereon. The properties of piezoelectric materials are well known in the literature; therefore the principles underlying their use in the art will be omitted, their practical implementation being within the reach of a person skilled in the art. By suitably adjusting the electric signal sent by the voltage generator, it is possible to obtain from the transducer 5 a production of pressure waves at frequencies higher than the human audibility range (ultrasound), treating the localised adiposities of the patient according to the cavitation mechanism
illustrated in the foregoing.
In particular, the device subject-matter of the present invention uses ultrasound with frequency values ranging from 35 kHz to 55 kHz. In fact, it was found that ultrasound emitted with these frequencies entail on adipocyte cells an action targeted at their dissolving, thus overcoming the problems related to similar devices present to date on the market, which as mentioned contribute to carry out only an action of removal of liquids stagnating inside adipose tissues. Preferably, a frequency value close to 40 KHz is set. Preferably, a frequency value close to 50 KHz is set. Finally, said grip member 30 comprises, at an edge thereof, a ring-shaped luminous indicator 9, active under conditions of use of the device. This provides an immediate reference for the operator, indicating the operativeness of the device itself. Finally, referring to figure 4, it is depicted a situation of use of the device 1 subject-matter of the present invention. In particular, it is shown the handle 3 brought into contact with a patient's skin at the piezoelectric transducer 5, attached onto the surface 31 of the steel plate 4. Body parts most often subject of the therapy are abdomen, girdle, hips (a body part also known as "saddle bags"), inner thighs and the back of the knees. The present invention has hereto been described with reference to a preferred embodiment thereof. It is understood that other embodiments might exist, all falling within the concept of the same invention, and all comprised within the protective scope of the claims hereinafter.
Claims
1. A device (1) to be used in ultrasound hydrolipoclasia therapy for cellulite and localised adiposity treatment, comprising:
• A voltage generator (2); • A control and adjustment unit (6) for controlling and adjusting said voltage generator (2);
• at least one handle (3) having a plate (4) of electric conductor material to which it is integral at least one transducer (5) apt to perform the transduction of an electric signal into acoustic pressure waves at ultrasound frequency;
• connecting means (26) between said voltage generator (2) and said at least one handle (3); and
• human-machine interface means (7), connected to said adjustment unit (6), said device (1) being characterised in that said ultrasound frequency has a value ranging from 35 KHz to 55 KHz.
2. The device (1) according to the preceding claim, wherein said plate (4) has a substantially cylindrical shape with a thickness of height equal to about 1.5 cm.
3. The device (1) according to claim 1 or 2, wherein said plate (4) is made of steel.
4. The device (1) according to any one of the preceding claims, wherein said transducer (5) is of piezoelectric type.
5. The device (1) according to any one of the preceding claims, wherein said transducer (5) has a substantially cylindrical shape and is attached directly on said plate (4) at a free circular surface (31) thereof.
6. The device according to the preceding claim, wherein said transducer (5) is attached in a concentric position with respect to said free circular surface (31).
7. The device (1) according to any one of the preceding claims, wherein said at least one handle (3) comprises a grip member (30).
8. The device (1) according to the preceding claim, wherein said grip member (30) comprises at an edge thereof a luminous indicator (9), active under operative conditions.
9. The device (1) according to the preceding claim, wherein said luminous indicator (9) is substantially ring-shaped.
10. The device (1) according to any one of the preceding claims, wherein said interface means comprises a keyboard and a display.
11. The device (1) according to any one of the preceding claims, wherein said interface means comprises a "touch - screen" type terminal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM20070148 ITRM20070148A1 (en) | 2007-03-21 | 2007-03-21 | DEVICE FOR THE PRODUCTION OF LOW FREQUENCY ULTRASOUNDS FOR LOCALIZED CELLULITE AND ADIPOSITY TREATMENT |
ITRM2007A000148 | 2007-03-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008114186A2 true WO2008114186A2 (en) | 2008-09-25 |
WO2008114186A3 WO2008114186A3 (en) | 2008-12-18 |
Family
ID=39764980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/050961 WO2008114186A2 (en) | 2007-03-21 | 2008-03-14 | Device for the production of low-frequency ultrasound for cellulite and localised adiposity treatment |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITRM20070148A1 (en) |
WO (1) | WO2008114186A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578060A (en) * | 1995-06-23 | 1996-11-26 | Chattanooga Group, Inc. | Physical therapy apparatus having an interactive interface, and method of configuring same |
EP1060728A1 (en) * | 1998-02-05 | 2000-12-20 | Miwa Science Laboratory Inc. | Ultrasonic wave irradiation apparatus |
EP1386597A1 (en) * | 2002-07-31 | 2004-02-04 | Joan Francesc Casas Boncompte | Ultrasound endomassage device |
US20060094988A1 (en) * | 2004-10-28 | 2006-05-04 | Tosaya Carol A | Ultrasonic apparatus and method for treating obesity or fat-deposits or for delivering cosmetic or other bodily therapy |
EP1844750A1 (en) * | 2006-04-12 | 2007-10-17 | Lain Electronic S.r.L. | Device for the treatment of cellulite and adipose tissue |
-
2007
- 2007-03-21 IT ITRM20070148 patent/ITRM20070148A1/en unknown
-
2008
- 2008-03-14 WO PCT/IB2008/050961 patent/WO2008114186A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578060A (en) * | 1995-06-23 | 1996-11-26 | Chattanooga Group, Inc. | Physical therapy apparatus having an interactive interface, and method of configuring same |
EP1060728A1 (en) * | 1998-02-05 | 2000-12-20 | Miwa Science Laboratory Inc. | Ultrasonic wave irradiation apparatus |
EP1386597A1 (en) * | 2002-07-31 | 2004-02-04 | Joan Francesc Casas Boncompte | Ultrasound endomassage device |
US20060094988A1 (en) * | 2004-10-28 | 2006-05-04 | Tosaya Carol A | Ultrasonic apparatus and method for treating obesity or fat-deposits or for delivering cosmetic or other bodily therapy |
EP1844750A1 (en) * | 2006-04-12 | 2007-10-17 | Lain Electronic S.r.L. | Device for the treatment of cellulite and adipose tissue |
Also Published As
Publication number | Publication date |
---|---|
WO2008114186A3 (en) | 2008-12-18 |
ITRM20070148A1 (en) | 2008-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10080906B2 (en) | Methods and devices for tissue treatment using mechanical stimulation and electromagnetic field | |
CN107582235B (en) | Cosmetic device for enhancing the recovery of mucosal tissue | |
US9433803B2 (en) | Method and system for destroying adipose tissue non-invasively and accelerating lipid metabolism | |
KR102696429B1 (en) | How to Treat Internal Organs, Injuries and Pain | |
US20180099162A1 (en) | Apparatus and method for treating electile disfunction applying transversal ultrasound waves | |
EP1844750A1 (en) | Device for the treatment of cellulite and adipose tissue | |
JP5235197B2 (en) | Device for treating cellulite and fat mass | |
JP2014501577A (en) | Pulsating massage device | |
WO2011077466A1 (en) | Ultrasound device for treating cellulite and localized adiposity | |
US20100100015A1 (en) | Ultrasound systems and methods for treatng ischemic limbs or tissue affected by peripheral arterial disease | |
JP2014500748A (en) | Knee joint treatment machine using high frequency | |
CA3142782A1 (en) | Device for acupuncture and moxibustion therapy and uses thereof | |
US11951335B2 (en) | Internal organ, injury and pain, pulmonary condition and adipose tissue treatment | |
RU2413492C2 (en) | Method of integrated cosmetic processing of patient's superficial tissues and related device for implementation thereof | |
WO2008114186A2 (en) | Device for the production of low-frequency ultrasound for cellulite and localised adiposity treatment | |
KR200217162Y1 (en) | Ultrasonic Belt | |
US20210236861A1 (en) | Portable ultrasonic stimulator | |
RU2812121C1 (en) | Method of influencing subcutaneous fat layer to reduce its volume | |
US20200324147A1 (en) | A Pain Relief, Fracture Healing and Spinal Fusion Device | |
KR102436432B1 (en) | Mobile ultrasonic stimulation apparatus | |
KR20200077863A (en) | Mobile ultrasonic stimulation apparatus | |
KR20210069255A (en) | High frequency control method for high frequency massage of delayed onset muscle soreness and high frequency treatment apparatus | |
CN206473672U (en) | Ultrasonic therapeutic equipment | |
CN102406982A (en) | Method and device for treating varicosity by ultrasonic waves | |
RU2698011C1 (en) | Method of treating burns by ultrasonic oscillations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08751087 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08751087 Country of ref document: EP Kind code of ref document: A2 |